Akero Therapeutics, Inc.
Industry: Life Sciences ・ $AKRO on Nasdaq
Insider Sale
+$135,000
-1.66%
Shares
Shares Volume: 5,000 Shares
Average Share Price: $27
INSIDER
Young Jonathan
Chief Operating Officer (Officer)
reported on Sep 5 2024
traded on Sep 3 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 296,854 |
| PURCHASES/SALES 1Y | 0 / 13 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $109,011.06 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 3 |
| PURCHASES/SALES 1Y | 2 / 40 |
| P/S VALUE RATIO | 0.215 |
| AVERAGE SALE VALUE | $428,464.2 |
| COMPANY PREVIOUS TRADES |